Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Acumen Pharmaceuticals Inc
ABOSCurrent price
2.61 USD
+0.04 USD (+1.56%)
Last closed
2.53 USD
Company
www.acumenpharm.com
ISIN
US00509G2093
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
196 460 944 USD
Yield for 12 month
+10.13 %
1Y
3Y
5Y
10Y
15Y
ABOS
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2 that completed Phase I clinical trial to target soluble amyloid-beta oligomers. The company has a license agreement with Lonza Sales AG to manufacture and commercialize sabirnetug; and a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia. Address: 427 Park Street, Charlottesville, VA, United States, 22902
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
11.2 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-42 318 000 USD
Last Year
-169 000 USD
Current Quarter
-45 000 USD
Last Quarter
-44 000 USD
Key Figures ABOS
1 year
3 years
5 years
10 years
EBITDA
-76 615 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-20.56 %
PEG Ratio
–
Return On Equity TTM
-31.43 %
Wall Street Target Price
11.2 USD
Revenue TTM
329 000 USD
Book Value
4.06 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-32 361 000 USD
Earnings per share
-1.11 USD
Diluted Eps TTM
-1.11 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ABOS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ABOS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ABOS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
89.674
Price Sales TTM
538.7842
Enterprise Value EBITDA
-0.5955
Price Book MRQ
0.8053
Financials ABOS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ABOS
For 52 weeks
2.01 USD
5.09 USD
50 Day MA
2.59 USD
Shares Short Prior Month
1 563 575
200 Day MA
3.09 USD
Short Ratio
8.32
Shares Short
1 268 677
Short Percent
2.84 %
BeatStart